Gonadotropin releasing hormone agonists: Expanding vistas
about
Gonadotropin-releasing hormone (GnRH) analogues for premenstrual syndrome (PMS)Hypothalamic neurohormones and immune responses.Evaluation of the treatment patterns and economic burden of dysmenorrhea in Japanese women, using a claims database.Stress urinary incontinence: What, when, why, and then what?Oral continuous combined 0.5 mg estradiol valerate and 5 mg dydrogesterone as daily add-back therapy during post-operative GnRH agonist treatment for endometriosis in Chinese women.Abnormal uterine bleeding in midlife: The role of levonorgestrel intrauterine system.Obstetrics-gynaecology and changed lifestyles of women.Unusual side effect from a luteinizing hormone-releasing hormone agonist, leuprorelin, in the treatment of prostate cancer: a case report.A comparison of progestogens or oral contraceptives and gonadotropin-releasing hormone agonists for the treatment of endometriosis: a systematic review.Adverse skeletal effects of drugs - beyond Glucocorticoids.Recent advances in oral delivery of peptide hormones.Formulation of 99mTechnetium-labeled leuprolide loaded liposomes and its biodistribution study in New Zealand white female rabbits for assessment of its uterine targeting efficiency.Assessment of ovarian function after chemotherapy in women with early and locally advanced breast cancer from Serbia.Red degeneration of a uterine fibroid following the administration of gonadotropin releasing hormone agonists.Heavy menstrual bleeding diagnosis and medical management.Establishing an Animal Model of Secondary Osteoporosis by Using a Gonadotropin-releasing Hormone Agonist.
P2860
Q24193315-EFC781E5-BC6D-4E3E-B32C-093DE5001BFBQ30450552-DE0D777A-E589-4D26-9D2E-B205A3BD33DAQ33734397-092C59C6-4AA3-4E6B-BD90-95199012D63DQ35811230-E9C64298-C400-4AF1-8206-C7F73FCE6406Q36449785-4EFAE8F8-0F7E-4CDE-A86E-91EA0A95218DQ36984317-8C6FC1C4-132B-424D-AA42-F496AA260512Q37391285-93417382-968B-4160-ABDC-A0E78D9B1D8DQ37410435-26812EC8-CA59-4463-AE06-086A73BEB996Q38192713-A86A2B57-8F6B-46F9-822B-8B479F8266EAQ38231316-565F1C4C-21DB-468E-9D92-EE9AC7808080Q38703514-AE5AB1D1-04F3-49BB-9A6D-E383109E0573Q47596256-8BF521A4-B649-4EA1-B6A2-61E1E3EB3907Q48365999-7F2A5CF3-4FD9-4803-AC6A-EB4D938FED7AQ50226917-CAFAF99E-E999-4032-AEBB-08E5ECB6E563Q54957411-3B7D5BCD-BFDC-48BC-8E62-92CAB0249585Q55015269-92EC3D7D-BD81-4427-A8CA-CFE40A054B62
P2860
Gonadotropin releasing hormone agonists: Expanding vistas
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Gonadotropin releasing hormone agonists: Expanding vistas
@ast
Gonadotropin releasing hormone agonists: Expanding vistas
@en
Gonadotropin releasing hormone agonists: Expanding vistas
@nl
type
label
Gonadotropin releasing hormone agonists: Expanding vistas
@ast
Gonadotropin releasing hormone agonists: Expanding vistas
@en
Gonadotropin releasing hormone agonists: Expanding vistas
@nl
prefLabel
Gonadotropin releasing hormone agonists: Expanding vistas
@ast
Gonadotropin releasing hormone agonists: Expanding vistas
@en
Gonadotropin releasing hormone agonists: Expanding vistas
@nl
P2860
P3181
P356
P1476
Gonadotropin releasing hormone agonists: Expanding vistas
@en
P2093
Navneet Magon
P2860
P3181
P356
10.4103/2230-8210.85575
P407
P577
2011-10-01T00:00:00Z